[Clinical significance of Her-2/neu status in patients with uterine papillary serous carcinoma].

Ren, Yu-lan; Wang, Hua-ying; Zhou, Xiao-yan; Shan, Bo-er; Yang, Wen-tao; Shen, Lei; Shi, Da-ren

Ren, Yu-lan; Wang, Hua-ying; Zhou, Xiao-yan; Shan, Bo-er; Yang, Wen-tao; Shen, Lei; Shi, Da-ren.

Affiliation

Ren YL; Department of Gynecologic Oncology, Cancer Hospital, Fudan University, Shanghai 200032, China.

Zhonghua Fu Chan Ke Za Zhi ; 45(5): 367-71, 2010 May.

Article in Zh | MEDLINE | ID: mdl-20646447

Subject(s)

Cystadenocarcinoma, Papillary/genetics; Gene Amplification; Genes, erbB-2/genetics; Receptor, ErbB-2/metabolism; Uterine Neoplasms/genetics; Adenocarcinoma/genetics; Adenocarcinoma/metabolism; Adenocarcinoma/pathology; Aged; Aged, 80 and over; Cystadenocarcinoma, Papillary/metabolism; Cystadenocarcinoma, Papillary/pathology; Cystadenocarcinoma, Serous/genetics; Cystadenocarcinoma, Serous/metabolism; Cystadenocarcinoma, Serous/pathology; Female; Humans; Immunohistochemistry; In Situ Hybridization/methods; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Receptor, ErbB-2/genetics; Retrospective Studies; Risk Factors; Uterine Neoplasms/metabolism; Uterine Neoplasms/pathology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uterine Neoplasms / Gene Amplification / Cystadenocarcinoma, Papillary / Receptor, ErbB-2 / Genes, erbB-2 Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Middle aged Language: Zh Journal: Zhonghua Fu Chan Ke Za Zhi Year: 2010 Document type: Article Affiliation country: China

Search on Google

Add to My VHL

XML

PubMed Links